Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 97,646 | 91,282 | -6,364 | $40.9K | $44.5K | 15.71% | +$3.5K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 2,114,444 | 2,766,390 | +651,946 | $25.3K | $43.6K | 15.41% | +$18.3K |
| BioMarin Pharmaceutical Inc.(BMRN) | 405,450 | 524,786 | +119,336 | $22.0K | $31.2K | 11.02% | +$9.2K |
| Jazz Pharmaceuticals plc(JAZZ) | 167,816 | 167,816 | 0 | $22.1K | $28.5K | 10.08% | +$6.4K |
| Exelixis, Inc.(EXEL) | 518,526 | 493,526 | -25,000 | $21.4K | $21.6K | 7.64% | +$216 |
| Avadel Pharmaceuticals | 955,860 | 855,860 | -100,000 | $14.6K | $18.4K | 6.51% | +$3.8K |
| Sanofi(SNY) | 323,946 | 323,946 | 0 | $15.3K | $15.7K | 5.54% | +$408 |
| Supernus Pharmaceuticals, Inc.(SUPN) | 363,479 | 313,499 | -49,980 | $17.4K | $15.6K | 5.50% | -$1.8K |
| Cardinal Health, Inc.(CAH) | 73,745 | 73,745 | 0 | $11.6K | $15.2K | 5.35% | +$3.6K |
| Indivior Plc | 339,532 | 339,532 | 0 | $8.2K | $12.2K | 4.30% | +$4.0K |
| Vanda Pharmaceuticals Inc.(VNDA) | 1,180,388 | 1,180,388 | 0 | $5.9K | $10.4K | 3.68% | +$4.5K |
| BioNTech SE(BNTX) | 79,366 | 99,523 | +20,157 | $7.8K | $9.5K | 3.35% | +$1.6K |
| GSK plc(GSK) | 271,729 | 96,729 | -175,000 | $11.7K | $4.7K | 1.68% | -$7.0K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 149,634 | +149,634 | $0 | $3.4K | 1.22% | +$3.4K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 4,000 | 4,000 | 0 | $2.2K | $3.1K | 1.09% | +$838 |
| Alkermes plc(ALKS) | 207,822 | 107,822 | -100,000 | $6.2K | $3.0K | 1.07% | -$3.2K |
| Biogen Inc.(BIIB) | 10,000 | 10,000 | 0 | $1.4K | $1.8K | 0.62% | +$359 |
| Evolus, Inc.(EOLS) | 100,000 | 100,000 | 0 | $614 | $665 | 0.23% | +$51 |